Annual sales fell from KRW 198.6 billion in 2022 to KRW 151.4 billion in 2023, a 23.8% decline, then to KRW 122 billion in 2024, down 19.4%, and to KRW 101.1 billion in 2025, down 17.1%.
The decline has run for three consecutive years from 2023 through 2025, with 2022 the largest year and 2025 the smallest in the 2022 to 2025 span.
Operating profit rose from KRW 4.54 billion in 2022 to KRW 10.5 billion in 2023, a 131.8% increase, then fell to KRW 4.93 billion in 2024, down 53.1%, and turned into an operating loss of KRW 2.27 billion in 2025. Operating margin moved from 2.3% in 2022 to 7.0% in 2023, 4.0% in 2024 and -2.2% in 2025.
Net profit attributable to controlling shareholders held at KRW 4.74 billion in 2022, KRW 4.61 billion in 2023 and KRW 4.81 billion in 2024 before turning into a net loss of KRW 2.42 billion in 2025.
Net profit including non-controlling interests, at a net loss of KRW 2.56 billion in 2025, is a separate figure and should be read apart from the controlling-shareholder line.
The company attributed the 2025 swing to intensified competition in the inner-beauty market that reduced sales, higher clinical, new-product and marketing spending to reshape its brand portfolio, higher development and marketing costs for new businesses and overseas expansion, and a temporary valuation loss at an investee.
Operating cash flow improved from negative KRW 3.63 billion in 2022 to KRW 11.2 billion in 2025, the largest of the four years. At the end of 2025, total equity stood at KRW 105.1 billion, equity attributable to controlling shareholders at KRW 103.8 billion, and total liabilities at KRW 31.6 billion.
Quarterly results moved from an operating profit of KRW 514 million and controlling-shareholder net profit of KRW 1.19 billion in the third quarter of 2025, to an operating loss of KRW 3.78 billion and a controlling-shareholder net loss of KRW 4.34 billion in the fourth quarter.
In 2026, the first quarter showed an operating loss of KRW 26.13 million, the second an operating profit of KRW 6.97 million, and the third an operating loss of KRW 2.36 billion, while sales were KRW 25.9 billion, KRW 28.4 billion and KRW 27.2 billion, with the third quarter up 7.0% year on year.
The second-quarter controlling-shareholder net profit of KRW 7.74 billion was far larger than its operating profit, so the gap between operating and non-operating items is a point to examine in the next periodic report.